HOOKIPA Pharma Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
HOOKIPA Pharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2024.
  • HOOKIPA Pharma Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.8M, a 33.3% increase year-over-year.
  • HOOKIPA Pharma Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $17.7M, a 50.5% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2023 was $16.5M, a 94.6% increase from 2022.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2022 was $8.47M, a 40.9% increase from 2021.
  • HOOKIPA Pharma Inc. annual Nonoperating Income (Expense) for 2021 was $6.01M, a 34.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.7M $4.8M +$1.2M +33.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $16.5M $3.36M -$93K -2.69% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $16.6M $3.28M +$95K +2.99% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $16.5M $6.24M +$4.73M +314% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $11.7M $3.6M +$891K +32.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $10.9M $3.46M +$1.38M +66.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.47M $3.18M +$1M +46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.47M $1.51M +$693K +85.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $7.78M $2.71M +$1.59M +141% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.19M $2.07M -$64K -3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.26M $2.18M +$245K +12.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $6.01M $813K -$1.91M -70.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-22
Q3 2021 $7.92M $1.13M -$1.69M -60% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $9.61M $2.14M +$2K +0.09% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $9.6M $1.93M +$401K +26.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $9.2M $2.72M -$153K -5.33% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $9.36M $2.82M +$617K +28% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $8.74M $2.13M +$484K +29.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $8.26M $1.53M +$207K +15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $8.05M $2.87M +$2.56M +829% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-24
Q3 2019 $5.49M $2.2M +$599K +37.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $4.89M $1.65M +$493K +42.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $4.39M $1.33M -$574K -30.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $4.97M $309K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 $1.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.16M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $1.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.